Supporting Employers in Addressing the Rising Costs & Lack of PBM Transparency

When:  Nov 17, 2016 from 01:00 PM to 03:00 PM (CT)
Associated with  Featured Content

Biologic and specialty drugs are emerging as effective treatments for complex “high touch” chronic conditions like multiple sclerosis, arthritis and cancer, giving hope to millions but at a high price tag. Given a full pipeline, the use and cost continues to grow at much faster pace than any other component of an employer-sponsored program. Recent PBM forecasts show U.S. spending on specialty drugs is projected to increase by well over 50% in the near future, and that 3 of the 4 costliest prescription therapy classes will be for specialty conditions.

MBGH research has identified that specialty drug costs are the #1 priority for self-insured employers and are interested in better understanding how to manage this challenging benefit.

During this webinar, participants will:

  • Gain insight on what employers are doing to more effectively manage specialty drug costs and patient outcomes
  • Identify ways to address PBM transparency in contracting and use of rebates and performance
  • Learn how significant the impact of middlemen are in adding to the cost of specialty drugs
  • Get access to MBGH’s no-cost online toolkit with resources, checklists, tip sheets and a consumer communications strategy to support employer efforts

Registration Information

Members $0
Employer Non-Members $25 Need a promo code?
Non-Members $75

Have a Question?

Ashley Piontkowski
(312) 372-9090 x105

Email Me!

Location

Dial-in Instructions:
Webinar registrants will receive a Readytalk email two days before the program from MBGH.
Event Image